(Q38736275)

6 September 2017

Neuroprotection Trials in Traumatic Brain Injury (English)

1 reference

6 September 2017

traumatic brain injury

0 references

author name string

Shamik Chakraborty

series ordinal

1

1 reference

6 September 2017

Brett Skolnick

series ordinal

2

1 reference

6 September 2017

Raj K Narayan

series ordinal

3

1 reference

6 September 2017

1 April 2016

1 reference

Current Neurology and Neuroscience Reports

6 September 2017

1 reference

6 September 2017

16

1 reference

6 September 2017

4

1 reference

6 September 2017

29

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-016-0625-x

6 September 2017

0 references

cites work

A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Trends in hospitalization associated with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

A review of traumatic brain injury trauma center visits meeting physiologic criteria from The American College of Surgeons Committee on Trauma/Centers for Disease Control and Prevention Field Triage Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Clinical trials in traumatic brain injury: past experience and current developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Neuroprotective strategies for traumatic brain injury: improving clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Current aspects of pathophysiology and cell dysfunction after severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Saline or albumin for fluid resuscitation in patients with traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Hypotension, hypoxia, and head injury: frequency, duration, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Cerebral autoregulation following head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Assessment of cerebrovascular autoregulation in head-injured patients: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Nitric oxide in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Cerebral circulation after head injury. 1. Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Posttraumatic vasospasm: the epidemiology, severity, and time course of an underestimated phenomenon: a prospective study performed in 299 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Molecular and cellular mechanisms in the pathophysiology of severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Cytokines and metabolic dysfunction after severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Brain hydroxyl radical generation in acute experimental head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Importance of aquaporins in the physiopathology of brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

A review of progress in understanding the pathophysiology and treatment of brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Clinical trials in head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Dexamethasone and severe head injury. A prospective double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Steroids CRASH out of head-injury treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Metabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Dosing and safety of cyclosporine in patients with severe brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

The efficacy of Cyclosporine-A on Diffuse Axonal Injury after Traumatic Brain Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Strategies for CNS repair following TBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Impact of an immune modulator fingolimod on acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Statins as anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Statins in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Potential roles for statins in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Effect of rosuvastatin on cytokines after traumatic head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Progesterone exerts neuroprotective effects after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Very early administration of progesterone for acute traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

A clinical trial of progesterone for severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Lack of effect of induction of hypothermia after acute brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Hypothermia for Intracranial Hypertension after Traumatic Brain Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Update of the stroke therapy academic industry roundtable preclinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Outcome prediction after mild and complicated mild traumatic brain injury: external validation of existing models and identification of new predictors using the TRACK-TBI pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Traumatic brain injury: an international knowledge-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-016-0625-X

Treatment window for hypothermia in brain injury

21 January 2018

1 reference

12 December 2020

A randomized trial of nimodipine in severe head injury: HIT I. British/Finnish Co-operative Head Injury Trial Group.

1 reference

12 December 2020

Role of calcium in central nervous system injuries

1 reference

12 December 2020

"Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group

1 reference

12 December 2020

Surveillance for traumatic brain injury-related deaths--United States, 1997-2007.

1 reference

12 December 2020

Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases

1 reference

12 December 2020

Calcium channel blockers for acute traumatic brain injury

1 reference

12 December 2020

10.1007/S11910-016-0625-X

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference